Abrogation of esophageal carcinoma development in miR-31 knockout rats

Autor: Karl J. Smalley, Ruiyan Jing, Sili Fan, Carlo M. Croce, Guidantonio Malagoli Tagliazucchi, Louise Y.Y. Fong, Oliver Fiehn, Joseph Altemus, Cristian Taccioli, Kay Huebner, Alexey Palamarchuk, John L. Farber
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Genome instability
Male
Medical Sciences
Knockout rat
Esophageal Neoplasms
Transgenic
law.invention
Transcriptome
Gene Knockout Techniques
0302 clinical medicine
law
Neoplasms
in vivo antimiR-31 delivery
constitutive miR-31 knockout rat
zinc deficiency
In vivo antimiR-31 delivery
2.1 Biological and endogenous factors
Aetiology
Cancer
Esophageal cancer rat model
0303 health sciences
Multidisciplinary
Tumor
Zinc deficiency
NF-kappa B
Biological Sciences
Constitutive miR-31 knockout rat
Esophageal squamous cell carcinoma
3. Good health
esophageal squamous cell carcinoma
Gene Expression Regulation
Neoplastic

mir-31
Zinc
030220 oncology & carcinogenesis
Rats
Transgenic

medicine.symptom
Biotechnology
Signal Transduction
Nitrosamines
Inflammation
Biology
Cell Line
Hypoxia-Inducible Factor-Proline Dioxygenases
03 medical and health sciences
Experimental
Rare Diseases
Esophagus
Cell Line
Tumor

Genetics
medicine
Carcinoma
Animals
Humans
neoplasms
Gene knockout
Nutrition
030304 developmental biology
Neoplastic
esophageal cancer rat model
Human Genome
Neoplasms
Experimental

medicine.disease
digestive system diseases
Rats
MicroRNAs
Gene Expression Regulation
Dietary Supplements
Cancer research
Carcinogens
Suppressor
Digestive Diseases
Zdroj: Proceedings of the National Academy of Sciences of the United States of America, vol 117, iss 11
Proceedings of the National Academy of Sciences of the United States of America
Popis: Significance ESCC is a deadly disease with few prevention or treatment options. In a dietary Zn deficiency-promoted rat ESCC model with miR-31–controlled inflammation pathway up-regulation, systemic antimiR-31 reduces miR-31 level and inflammation, suppressing ESCC development. We identified Egln3 as a direct miR-31 target and developed a constitutive miR-31 knockout rat model. Interactions of oncogenic miR-31, EGLN3 down-regulation, and inflammation occur in rat and human ESCC tissue. Since miR-31 genetic knockout prevents Zn deficiency-associated ESCC by eliminating or greatly reducing the entire miR-31-EGLN3/STK40-NF-κB–controlled inflammatory process, we conclude that miR-31 and downstream signaling proteins should be tested as prognostic and therapeutic targets and inexpensive Zn supplementation should be implemented for ESCC prevention in deficient populations.
MicroRNA-31 (miR-31) is overexpressed in esophageal squamous cell carcinoma (ESCC), a deadly disease associated with dietary Zn deficiency and inflammation. In a Zn deficiency-promoted rat ESCC model with miR-31 up-regulation, cancer-associated inflammation, and a high ESCC burden following N-nitrosomethylbenzylamine (NMBA) exposure, systemic antimiR-31 delivery reduced ESCC incidence from 85 to 45% (P = 0.038) and miR-31 gene knockout abrogated development of ESCC (P = 1 × 10−6). Transcriptomics, genome sequencing, and metabolomics analyses in these Zn-deficient rats revealed the molecular basis of ESCC abrogation by miR-31 knockout. Our identification of EGLN3, a known negative regulator of nuclear factor κB (NF-κB), as a direct target of miR-31 establishes a functional link between oncomiR-31, tumor suppressor target EGLN3, and up-regulated NF-κB–controlled inflammation signaling. Interaction among oncogenic miR-31, EGLN3 down-regulation, and inflammation was also documented in human ESCCs. miR-31 deletion resulted in suppression of miR-31–associated EGLN3/NF-κB–controlled inflammatory pathways. ESCC-free, Zn-deficient miR-31−/− rat esophagus displayed no genome instability and limited metabolic activity changes vs. the pronounced mutational burden and ESCC-associated metabolic changes of Zn-deficient wild-type rats. These results provide conclusive evidence that miR-31 expression is necessary for ESCC development.
Databáze: OpenAIRE